SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000014
Filing Date
2024-01-04
Accepted
2024-01-04 18:06:42
Documents
2
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 7748
2 poa.htm EX-24 11355
  Complete submission text file 0001610717-24-000014.txt   20484
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 369 27TH STREET SAN FRANCISCO CA 94131
Business Address
Krause Kevin Michael (Reporting) CIK: 0001916925 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 24513650